FDA requests more data on inhaled insulin
Links shared publicly online about this topic.
- 567total visits
FDA requests more data on inhaled insulin
View full resource at endocrinetoday.com
Tags: Insulin, Clinical Trial, FDA
Most Recently Shared on January 20, 2011 at 4:41 pm By:
RT @drexelendo: RT @EndocrineToday: #FDA requests more data on inhaled #insulin http://bit.ly/frwSGG
Also Shared By:
FDA seeks more data on MannKind's inhaled insulin | Reuters
feeds.reuters.com — “BOSTON (Reuters) - U.S. regulators have requested more information on an inhaled insulin device being developed by MannKind Corp, sending the company's shares down 24.7 percent. MannKind said on Monday” View full resource at feeds.reuters.com
Most Recently Shared on March 16, 2010 at 7:27 am By:
FDA seeks more data on MannKind's inhaled insulin http://link.reuters.com/zur93j
FDA seeks more data on MannKind's inhaled insulin | Reuters
reuters.com — “BOSTON (Reuters) - U.S. regulators have requested more information on an inhaled insulin device being developed by MannKind Corp, sending the company's shares down 24.7 percent. MannKind said on Monday” View full resource at reuters.com
Most Recently Shared on March 16, 2010 at 4:30 am By:
Hisham Rana, MD Doctor and Physician
News: FDA seeks more data on MannKind's inhaled insulin http://bit.ly/9kiGXu - #diabetes #health
FDA seeks more data on MannKind's inhaled insulin | Reuters
feeds.reuters.com — “BOSTON (Reuters) - U.S. regulators have requested more information on an inhaled insulin device being developed by MannKind Corp, sending the company's shares down 24.7 percent. MannKind said on Monday” View full resource at feeds.reuters.com
Most Recently Shared on March 15, 2010 at 8:51 pm By:
FDA seeks more data on MannKind's inhaled insulin http://link.reuters.com/nam93j
UPDATE 4-FDA seeks more data on MannKind's inhaled insulin | Reuters
reuters.com — “* FDA requests available data on Afrezza clinical utility * Seeks comparability information on commercial version * Asks for updated safety data; cites no safety concerns * Shares fall 24.7 pct” View full resource at reuters.com
Most Recently Shared on March 15, 2010 at 2:20 pm By:
Lisa Richwine Health Communicator
MNKD says FDA requests include currently available data that back clinical utility of Afrezza inhaled insulin http://link.reuters.com/gef93j
Advertisement
Endocrine Today
@EndocrineToday
#FDA requests more data on inhaled #insulin http://bit.ly/frwSGG
1 year ago...